Survival disparities following surgery among patients with different histological types of non-small cell lung cancer
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 140, 55-58
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Introduction to the Analysis of Survival Data in the Presence of Competing RisksCirculation, 2016
- Japanese Lung Cancer Registry Study of 11,663 Surgical Cases in 2004: Demographic and Prognosis Changes Over DecadeJournal of Thoracic Oncology, 2011
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine, 2010
- Competing Risk Regression Models for Epidemiologic DataAmerican Journal of Epidemiology, 2009
- Survival after Surgery in Stage IA and IB Non–Small Cell Lung CancerAmerican Journal of Respiratory and Critical Care Medicine, 2008
- The IASLC Lung Cancer Staging Project: Validation of the Proposals for Revision of the T, N, and M Descriptors and Consequent Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology, 2007
- Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trialThe Lancet Oncology, 2006
- Meta-Analysis of Postoperative Adjuvant Chemotherapy With Tegafur-Uracil in Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2005
- Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004